FDA delays Moderna for adolescents to review rare side effect

FDA delays Moderna for adolescents to review rare side effect The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -1.69% COVID-19 vaccine for adolescents to assess whether the shot may lead to heightened risk of a rare inflammatory heart condition, according to people familiar with the matter. https://ift.tt/3mV6d0B https://ift.tt/3jv70F9 October 16, 2021 at 12:21AM